Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5289570
Max Phase: Preclinical
Molecular Formula: C23H30N2O5S2
Molecular Weight: 478.64
Associated Items:
ID: ALA5289570
Max Phase: Preclinical
Molecular Formula: C23H30N2O5S2
Molecular Weight: 478.64
Associated Items:
Canonical SMILES: COc1ccc(S(=O)(=O)N2CC(C)(C)C(CCSCc3ccccc3)C2C(=O)NO)cc1
Standard InChI: InChI=1S/C23H30N2O5S2/c1-23(2)16-25(32(28,29)19-11-9-18(30-3)10-12-19)21(22(26)24-27)20(23)13-14-31-15-17-7-5-4-6-8-17/h4-12,20-21,27H,13-16H2,1-3H3,(H,24,26)
Standard InChI Key: APCLVQAXJIHPKK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 478.64 | Molecular Weight (Monoisotopic): 478.1596 | AlogP: 3.54 | #Rotatable Bonds: 9 |
Polar Surface Area: 95.94 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.71 | CX Basic pKa: | CX LogP: 3.53 | CX LogD: 3.51 |
Aromatic Rings: 2 | Heavy Atoms: 32 | QED Weighted: 0.33 | Np Likeness Score: -0.69 |
1. Mondal S, Adhikari N, Banerjee S, Amin SA, Jha T.. (2020) Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview., 194 [PMID:32224379] [10.1016/j.ejmech.2020.112260] |
Source(1):